Prednisone

is prescribed to treat:

• Inflammation, allergies, asthma, and autoimmune conditions • Various related conditions in the respiratory category • Associated symptoms and complications

It is an important medication that helps manage these conditions effectively.

Prednisone is an oral corticosteroid used across an unusually wide range of inflammatory and immune conditions — rheumatoid arthritis, polymyalgia rheumatica, temporal arteritis, asthma and COPD exacerbations, inflammatory bowel disease, and lupus among many others. It is one of the most effective drugs in medicine and one of the most consequential to use casually, because its harms accumulate silently with cumulative dose and duration.

Mechanism of Action

Prednisone is a prodrug converted in the liver to prednisolone, the active form. Prednisolone binds intracellular glucocorticoid receptors, and the receptor complex moves to the nucleus where it alters transcription of a broad set of genes — suppressing pro-inflammatory cytokines, chemokines, and adhesion molecules while inducing anti-inflammatory mediators.

The breadth of that transcriptional effect explains both the efficacy and the toxicity. The same receptor sits in bone, muscle, skin, the hypothalamic-pituitary-adrenal axis, the eye, and pancreatic and hepatic tissue governing glucose handling. There is no way to suppress inflammation through this mechanism without also affecting those tissues, which is why corticosteroid strategy is fundamentally about dose and duration rather than about avoiding side effects.

A second, faster non-genomic effect accounts for the symptomatic relief many patients feel within hours, before transcriptional changes could plausibly explain it. Prednisone has an intermediate duration of action, which permits once-daily morning dosing that roughly mirrors the body's own cortisol rhythm and reduces — though does not eliminate — adrenal suppression.

Clinical Use

Prednisone spans everything from a short burst for an asthma exacerbation to years of low-dose therapy in polymyalgia rheumatica. The clinical judgment is almost entirely about the dose-duration product, because most serious adverse effects track cumulative exposure rather than peak dose.

Short courses of one to two weeks rarely cause lasting harm and generally need no taper, since the HPA axis has not had time to suppress. Beyond about three weeks, tapering becomes necessary to allow adrenal recovery, and after months of therapy, that recovery can take many months more. Patients frequently underestimate this and stop on their own, which risks adrenal insufficiency presenting as fatigue, nausea, hypotension, and — during an intercurrent illness — adrenal crisis.

In conditions requiring prolonged control, the strategy is usually to establish control with prednisone and then introduce a steroid-sparing agent — methotrexate, hydroxychloroquine, sulfasalazine, or a biologic — so the steroid can be tapered off. A patient still on prednisone a year later without a documented sparing plan is a patient whose regimen deserves revisiting. The polymyalgia and temporal arteritis article covers two conditions where this arc is especially typical, and the MedlinePlus prednisone entry sets out the prescribing detail.

Monitoring and Follow-Up

Monitoring scales with expected duration. For anything beyond a short burst, check blood pressure, weight, and glucose, since corticosteroids raise blood sugar substantially — often unmasking diabetes or destabilising established diabetes within days. Steroid-induced hyperglycemia is characteristically worst in the afternoon and evening after a morning dose, so a fasting glucose alone can miss it entirely.

Bone protection deserves attention early rather than late. Prednisone causes rapid bone loss, with the fastest decline in the first six to twelve months, so patients expected to remain on it for three months or more should have calcium and vitamin D intake addressed, a bone density measurement, and consideration of a bisphosphonate. The bone health article covers the broader picture.

Other monitoring includes periodic assessment for cataracts and raised intraocular pressure with prolonged use, watching for mood change and insomnia, which can appear within days, and awareness of infection risk — corticosteroids blunt the inflammatory response that would normally signal infection, so a serious infection can present atypically and late. Our immunology and musculoskeletal teams manage the conditions where long-term steroids are most often needed. The NIAMS corticosteroid resource covers the bone considerations in more depth.

Special Populations

In older adults, every major adverse effect is amplified — bone loss on top of age-related loss, glucose intolerance on top of reduced reserve, and a higher risk of delirium and mood disturbance. Doses should be the minimum that controls the disease.

In pregnancy, prednisone is used when needed; only a small fraction crosses to the fetus because placental enzymes inactivate it, which is why prednisone is preferred over dexamethasone when treating the mother rather than the fetus. In diabetes, insulin or oral agent doses frequently need temporary increases during a course, and patients should be told this in advance rather than discovering it through a week of high readings. Live vaccines are generally avoided at immunosuppressive doses. Anyone on long-term therapy should carry information identifying them as steroid-dependent, because illness, injury, or surgery may require stress dosing.

Timing and formulation both help. Taking the full dose once in the morning aligns with the body's own cortisol peak and reduces both insomnia and the degree of adrenal suppression compared with divided dosing. Taking it with food limits gastric irritation. Where the disease permits, alternate-day dosing reduces adrenal suppression further, though it controls some conditions less well. For inflammation confined to one joint or one organ, a local injection or a topical, inhaled, or enteric-targeted formulation such as budesonide delivers the anti-inflammatory effect with a fraction of the systemic exposure, and is worth considering before committing to an oral course.

When to Contact Your Doctor

Seek urgent care for fever or signs of infection, since these may be blunted and can progress quickly. Report severe abdominal pain, black stools, or vomiting blood, particularly if you also take an NSAID such as ibuprofen, because that combination markedly raises ulcer risk. Marked mood change, agitation, confusion, or insomnia should be reported promptly rather than tolerated. New visual blurring or eye pain warrants assessment. Profound fatigue, dizziness, nausea, or vomiting during or after a taper may indicate adrenal insufficiency and needs same-day attention. Never stop prednisone abruptly after more than a few weeks of use.

To review your steroid dose, plan a taper, or discuss a steroid-sparing alternative, contact us or schedule a visit.